Apêndice 1 Caracterização dos estudos incluídos na RS Prevalência de complicações sistêmicas da COVID 19 em pacientes críticos: Revisão sistemática com metanálises
To evaluate the real-world incidence of cardiovascular adverse events (CVAE) and clinical outcomes among patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with
Background: Cardiovascular (CV) adverse events (AEs), especially atrial fibrillation (AF) and hypertension, have been reported in patients receiving treatments for chronic lymphocytic leukemia (CLL),
